Immunity for the long haul: Why some antibodies are built to last
A team of researchers from the University of Osaka found that cells producing IgG1 antibodies have advantages over those producing IgM antibodies, including better antigen presentation, survival, and bone marrow migration. These advantages may lead to long-term immune protection and inform the development of more effective vaccines.
SourceImmunology Frontier Research Center (IFReC) - The University of Osaka·JournalScience Immunology·TypeExperimental study·DateSep 8, 2026